The latest research consisting of a murine model of acute respiratory distress syndrome (ARDS) indicates that cannabidiol (CBD) help the lungs recover from excessive inflammation. This early evidence shows that CBD could help patients showing signs of respiratory distress avoid interventions like mechanical ventilation and death from acute respiratory distress syndrome (ARDS). “ARDS is a major killer in severe cases of some respiratory viral infections, including SARS-CoV-2 and we have an urgent need for better intervention and treatment strategies,” stated Dr. Babak Baban, Immunologist and Interim Associate Dean for Research at Dental College of Georgia at Augusta University. Dr. Babak Baban is the corresponding author of the study published in the Journal Cannabis and Cannabinoid Research. The study’s co-author Dr. Jack Yu, a Physician-Scientist and Chief of Paediatric Plastic Surgery at the Medical College of Georgia at Augusta University, further explained that the CBD research indicates pure CBD can help the lungs recover from the cytokine storm caused by the COVID-19 virus and restore healthier oxygen levels in the body. The Sars-CoV-2 Research To safely study the effects viruses, the researchers worked on a lung model that duplicates the damage caused by ARDS. The result? The team stated the overcharged…